Kim N D, Kang K W, Kang S Y, Vanhoutte P M
Laboratory of Pharmacology, College of Pharmacy, Seoul National University, Korea.
J Cardiovasc Pharmacol. 1999 Jul;34(1):148-52. doi: 10.1097/00005344-199907000-00023.
This study was designed to determine whether the alpha2-adrenoceptor antagonists idazoxan, yohimbine, and rauwolscine cause endothelium-dependent and -independent responses in the rat aorta. Rings of rat aorta, with and without endothelium, were suspended for the measurement of isometric force in modified Krebs-Ringer bicarbonate solution (37 degrees C; aerated with 95% O2 and 5% CO2). The alpha2-adrenoceptor antagonists, in the concentration range of 10(-8)-10(-6) M, relaxed phenylephrine-contracted rings with, but not those without endothelium. alpha2-Adrenoceptor antagonists (3 x 10(-6) M for 1 min) increased the accumulation of cyclic guanosine monophosphate (cGMP) about twofold in the aortas with endothelium. The relaxation and the increased cGMP induced by alpha2-antagonists were attenuated by methylene blue (10(-6) M) and N(G)-nitro-L-arginine (L-NA, 3 x 10(-5) M), whereas propranolol (10(-6) M) did not affect the relaxation. In concentrations >10(-6) M, alpha2-adrenoceptor antagonists relaxed the rat aorta without endothelium. The endothelium-independent relaxation by alpha2-adrenoceptor antagonists was abolished by increased external K+ and reduced significantly by tetraethylammonium (TEA, 10(-2) M, a Ca2+-dependent K+ channel blocker), but not inhibited by glibenclamide (10(-5) M, an ATP-sensitive K+ channel blocker). In the rabbit aorta, only endothelium-independent relaxations were observed with alpha2-adrenoceptor antagonists in the concentration range of 10(-8)-10(-5) M, and these relaxations were not antagonized by TEA. These results suggest that alpha2-adrenoceptor antagonists relax the rat aorta through endothelium-dependent mechanism at lower concentrations and endothelium-independent mechanisms at higher concentrations. The endothelium-dependent relaxations are likely to be mediated by the endothelium-derived relaxing factor (EDRF)/NO pathway because they are associated with the accumulation of cGMP, whereas the endothelium-independent relaxations may be caused by the opening of potassium channels in the vascular smooth muscle.
本研究旨在确定α2-肾上腺素能受体拮抗剂咪唑克生、育亨宾和萝芙素是否会在大鼠主动脉中引起内皮依赖性和非内皮依赖性反应。将有内皮和无内皮的大鼠主动脉环悬挂在改良的克雷布斯-林格碳酸氢盐溶液(37℃;用95%O2和5%CO2充气)中,用于测量等长力。α2-肾上腺素能受体拮抗剂在10(-8)-10(-6)M的浓度范围内,可使有内皮的苯肾上腺素收缩环舒张,但对无内皮的环无此作用。α2-肾上腺素能受体拮抗剂(3×10(-6)M,作用1分钟)可使有内皮的主动脉中环磷酸鸟苷(cGMP)的积累增加约两倍。α2-拮抗剂诱导的舒张和cGMP增加被亚甲蓝(10(-6)M)和N(G)-硝基-L-精氨酸(L-NA,3×10(-5)M)减弱,而普萘洛尔(10(-6)M)不影响舒张。在浓度>10(-6)M时,α2-肾上腺素能受体拮抗剂可使无内皮的大鼠主动脉舒张。α2-肾上腺素能受体拮抗剂的非内皮依赖性舒张被细胞外钾离子增加所消除,并被四乙铵(TEA,10(-2)M,一种钙依赖性钾通道阻滞剂)显著降低,但不受格列本脲(10(-5)M,一种ATP敏感性钾通道阻滞剂)抑制。在兔主动脉中,在10(-8)-10(-5)M的浓度范围内,α2-肾上腺素能受体拮抗剂仅观察到非内皮依赖性舒张,且这些舒张不被TEA拮抗。这些结果表明,α2-肾上腺素能受体拮抗剂在较低浓度时通过内皮依赖性机制使大鼠主动脉舒张,在较高浓度时通过非内皮依赖性机制舒张。内皮依赖性舒张可能由内皮源性舒张因子(EDRF)/一氧化氮(NO)途径介导,因为它们与cGMP的积累有关,而非内皮依赖性舒张可能由血管平滑肌中钾通道的开放引起。